Study Stopped
Combination of departure of Investigator from one site and slow recruitment rate
A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement
Randomised, Prospective, Post-Market Surveillance Study Comparing the Outcomes of Minimally Invasive and Conventional Surgical Procedures in Subjects Requiring Primary Total Hip Arthroplasty for Osteoarthritis.
1 other identifier
interventional
58
1 country
2
Brief Summary
The purpose of this study is to compare the short-term outcomes of two surgical techniques, minimally invasive and conventional, when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to undergo surgery using the minimally invasive or conventional surgical technique and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments with a focus on short term rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2005
Longer than P75 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedStudy Start
First participant enrolled
October 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedMay 11, 2016
March 1, 2016
2.2 years
September 13, 2005
May 9, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of hours post-operatively after which subjects are first able to mobilise with a frame or crutches
First post-operative day
Level of assistance required to perform 3 functional tasks (supine to sit, sit to stand and bed to chair transfer)on the second post-operative day
Second post-operative day
Time taken (in seconds) for subjects to walk 10 metres on the second post-operative day.
Second post-operative day
Amount of time (in seconds) for which subjects are able to stand on the operative leg on the second post-operative day.
Second post-operative day
Secondary Outcomes (8)
Haematological parameters assessed over a 56 hours post op
56 hours post-operatively
Pain levels and wound condition
Until discharge
Trendelenberg sign
Until discharge and at 6 weeks
Day of discharge
Until discharge
Activity levels over specified distances
Until discharge
- +3 more secondary outcomes
Study Arms (2)
1
ACTIVE COMPARATORDePuy MI System
2
ACTIVE COMPARATORConventional surgical technique
Interventions
A conventional surgical technique used in total hip replacement
Eligibility Criteria
You may qualify if:
- i) Male or female subjects, aged between 18 and 75 years inclusive.
- ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
- iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
- iv) Subjects with a primary diagnosis of osteoarthritis.
- v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.
You may not qualify if:
- i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery.
- ii) Women who are pregnant.
- iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
- iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
- v) Subjects who are currently involved in any injury litigation claims.
- vi) Subjects with a Body Mass Index (BMI) \> 30.
- vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration.
- viii) Subjects requiring a simultaneous bilateral total hip arthroplasty.
- ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rotherham General Hospitals NHS Trust
Rotherham, South Yorkshire, United Kingdom
Warwick Hospital NHS Trust
Warwick, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
October 1, 2005
Primary Completion
December 1, 2007
Study Completion
November 1, 2014
Last Updated
May 11, 2016
Record last verified: 2016-03